Medy-Tox Inc. (KOSDAQ:086900)

Medy-Tox Revenue

Medy-Tox had revenue of 63.96B KRW in the quarter ending March 31, 2025, with 17.16% growth. This brings the company's revenue in the last twelve months to 237.99B, up 2.13% year-over-year. In the year 2024, Medy-Tox had annual revenue of 228.62B with 3.39% growth.

• Revenue (ttm): 237.99B
• Revenue Growth: +2.13%
• P/S Ratio: 4.86
• Revenue / Employee: 328.72M
• Employees: 724
• Market Cap: 1,156.09B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	228.62B	7.50B	3.39%
Dec 31, 2023	221.12B	26.02B	13.34%
Dec 31, 2022	195.10B	10.23B	5.53%
Dec 31, 2021	184.87B	44.04B	31.27%
Dec 31, 2020	140.83B	-65.07B	-31.60%